Kindred Biosciences reported $11.26M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adma Biologics ADMA:US $ 32.34M 14.15M
Bayer BAYN:GR € 28727M 801M
Dynavax Technologies DVAX:US $ 528.93M 324.29M
Eli Lilly And LLY:US $ 13682M 1411.2M
Idexx Laboratories IDXX:US $ 633.85M 17.96M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Kindred Biosciences KIN:US $ 11.26M 4.71M
Minerva Neurosciences NERV:US $ 3.08M 1.36M
Novavax NVAX:US $ 1753.42M 101.9M
Phibro Animal Health PAHC:US $ 152.59M 11.53M
Zoetis ZTS:US $ 1471M 620M